Join the discussion.

STAY UP TO DATE ON THE MOST IMPORTANT ISSUES IN GENETICS TODAY.

Back to full list

Past Webinars

Next-generation sequencing (NGS)-based detection of deletions and duplications in heritable cardiovascular conditions

Matteo Vatta Ph.D., FACMG
May 24, 2017
Series: Leading with Science
View Recording

Next-generation sequencing (NGS) effectively detects both del/dup events and sequence alterations, and has a number of advantages over traditional techniques. Intended for genetic counselors, physicians, and other healthcare providers, this presentation will help you to:

  • Understand how next-generation sequencing (NGS) can detect both del/dup events and sequence alterations
  • Assess the advantages of NGS-based del/dup detection, including improved coverage compared to traditional techniques
  • Describe the frequency of del/dup events in heritable cardiovascular conditions

Dr. Vatta is a clinical molecular geneticist with more than 20 years of experience in cardiovascular genetic research and 10 years in cardiovascular genetic diagnostics. Before joining Invitae, Dr. Vatta was the Director of the Cardiovascular Genetics Section at the Indiana University Molecular Genetics Diagnostic Laboratory in the Division of Diagnostic Genomics and Associate Professor of Clinical Medical and Molecular Genetics at Indiana University. There, he led the development and launch of next-generation sequencing analysis for clinical testing. Dr. Vatta received his Ph.D. in molecular genetics from the Scuola Internazionale Superiore di Studi Avanzati/International School of Advanced Studies (SISSA/ISAS) in Trieste, Italy, with a thesis on the “Molecular Genetic Approach to the Study of Dilated Cardiomyopathy." 


What is the role of DNA diagnostics in cardiovascular medicine?

Robert Nussbaum, MD
March 28, 2017
Series: Invitae Insights
View Recording

Looking for insights into the care of families with inherited cardiovascular diseases and the implications for genetic testing? This webinar describes the role of DNA diagnostics in cardiovascular medicine. Intended for genetic counselors, physicians, and other healthcare providers, the presentation will help you better:

  • Understand the role of genetic testing in the diagnosis and management of cardiovascular disease
  • Identify patients who are most likely to benefit from genetic testing
  • Interpret genetic test results confidently

Dr. Nussbaum has served as Invitae’s Chief Medical Officer since August 2015. Prior to joining Invitae, he was chief of the Division of Genomic Medicine at UCSF Health, where he also held leadership roles in the Cancer Genetics and Prevention Program beginning in January 2009 and the Program in Cardiovascular Genetics beginning in July 2007. From April 2006 to August 2015, he served as a member of the UCSF Institute for Human Genetics. Prior to joining UCSF Health, Dr. Nussbaum was chief of the Genetic Disease Research Branch of the National Human Genome Research Institute, one of the National Institutes of Health, from 1994 to 2006.

He is a member of the Institute of Medicine and a fellow at the American Academy of Arts and Sciences. Dr. Nussbaum is a board-certified internist and medical geneticist who holds a B.S. in Applied Mathematics from Harvard College and an M.D. from Harvard Medical School in the Harvard-MIT joint program in Health Sciences and Technology. He completed his residency in internal medicine at Barnes-Jewish Hospital and a fellowship in medical genetics at the Baylor College of Medicine.

Topic: Cardiology

Diagnostic and therapeutic approaches to catecholaminergic polymorphic ventricular tachycardia (CPVT)

Silvia Priori, M.D., Ph.D.
February 02, 2017
Series: Invitae Insights
View Recording

We are pleased to jointly present a three part medical education webinar series with the Sudden Arrhythmia Death Syndromes (SADS) Foundation. The series is designed to educate genetic counselors, physicians, and other healthcare providers about the care of families with inherited arrhythmias and implications for genetic testing.

In this third webinar, Silvia Priori, M.D., Ph.D. presents the latest diagnostic and therapeutic approaches to catecholaminergic polymorphic ventricular tachycardia (CPVT). 

Professor Priori is full professor of cardiology at the University of Pavia (Italy), general scientific director of the IRCCS Fondazione Salvatore Maugeri, director of cardiac rehabilitation, and head of the molecular cardiology laboratories at the IRCCS Fondazione Salvatore Maugeri. Professor Priori is also director of the cardiovascular genetics program at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid, Spain.

Professor Priori's research laboratories have helped to define the fundamental mechanisms of arrhythmogenesis and abnormalities of intracellular calcium that cause sudden cardiac death in patients with inherited arrhythmias. More recently, Professor Priori’s research has focused on the development of molecular therapies for inherited arrhythmias.

Topic: Cardiology
Tags: CPVT